A study for a 23 year old woman who takes Rifampin, Isoniazid, Ethambutol Hydrochloride - from FDA reports

205 females aged 23 (±5) who take the same drugs are studied. This is a personalized study for a 23 year old female patient who has Tuberculosis - Disseminated. The study is created by eHealthMe based on reports from FDA.

On May, 25, 2018

205 females aged 23 (±5) who take Rifampin, Isoniazid, Ethambutol Hydrochloride are studied.

Number of reports submitted per year:

Rifampin, Isoniazid, Ethambutol Hydrochloride for a 23-year old woman.

Information of the patient in this study:

  • Age: 23
  • Gender: female
  • Conditions: Tuberculosis - Disseminated
  • Drugs taken:
    • Rifampin (rifampin)
    • Isoniazid (isoniazid)
    • Ethambutol Hydrochloride (ethambutol hydrochloride)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Cough: 2 (0.98% of females aged 23 (±5) who take the drugs)
  • Vomiting Blood: 0 (0% of females aged 23 (±5) who take the drugs)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common drug interactions over time

< 1 month:
  1. Acute generalised exanthematous pustulosis (acute febrile drug eruption)
  2. Anaemia (lack of blood)
  3. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  4. Pleural effusion (water on the lungs)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
1 - 6 months:
  1. Fever
  2. Acute generalised exanthematous pustulosis (acute febrile drug eruption)
  3. Diarrhea
  4. Cytolytic hepatitis (dissolution or destruction of a liver cell)
  5. Alanine aminotransferase increased
6 - 12 months:
  1. Breathing difficulty
  2. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  3. Toxoplasmosis (a parasitic disease caused by the protozoan toxoplasma gondii)
  4. Lymphocyte count decreased
  5. Cd4 lymphocytes decreased
1 - 2 years:
  1. Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Drug level decreased
  4. Pericarditis (inflammation of the pericardium)
  5. Interstitial lung disease
2 - 5 years:
5 - 10 years:
10+ years:
not specified:
  1. Fever
  2. Nausea and vomiting
  3. Alanine aminotransferase increased
  4. Aspartate aminotransferase increased
  5. Lymph follicular hypertrophy (an increase in the size of the lymph node follicles)

Top conditions involved for these people *:

  1. Hiv Infection : 35 people, 17.07%
  2. Lymph Node Tuberculosis : 13 people, 6.34%
  3. Preventive Health Care : 7 people, 3.41%
  4. Pseudomembranous Colitis (antibiotic-associated diarrhoea (aad), is an infection of the colon): 5 people, 2.44%
  5. Gastric Ulcer (stomach ulcer): 4 people, 1.95%

Top co-used drugs for these people *:

  1. Pyrazinamide (89 people, 43.41%)
  2. Levofloxacin (18 people, 8.78%)
  3. Efavirenz (17 people, 8.29%)
  4. Combivir (10 people, 4.88%)
  5. Lamivudine (9 people, 4.39%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

You are not alone: Connect with people like you, or share your experience to help people like you.

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

You may be interested in these posts

More posts for: Rifampin, Isoniazid, Ethambutol hydrochloride, Cough, Vomiting blood, Tuberculosis - disseminated

Related tests

We suggest these affordable tests for self monitoring. You can order them and receive results on eHealthMe. No doctor referral or insurance necessary.

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.